Price Alert

AgeX Therapeutics Inc. (AGE)

AMEX: AGE · Real-Time Price · USD

11.10

-1.50 (-11.90%)

At close: Mar 26, 2024, 8:59 PM

AgeX Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	4.27M	3.67M	3.19M	6.06M	8.71M	345K	397K	261K	280K	645K	466K	702K	448K	584K	731K	615K	809K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	10.6M	10.43M	10.25M	10.08M	50K	50K	50K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	383K	50K	50K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	50K	50K	50K	50K
Receivables	n/a	n/a	n/a	n/a	65K	57K	71K	6K	6K	4K	1K	12K	n/a	25K	24K	11K	48K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.49M	2M	2.24M	2.85M	166K	352K	673K	1.08M	1.46M	1.8M	720K	1.01M	1.38M	1.63M	720K	930K	1.28M
Total Current Assets	5.75M	5.68M	5.42M	8.92M	8.94M	754K	1.14M	1.35M	1.75M	2.45M	1.19M	1.73M	1.83M	2.23M	1.48M	1.56M	2.14M
Property-Plant & Equipment	977K	1.05M	1.12M	1.2M	1.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	509K	541K	574K	607K	640K	673K	705K	738K	771K	804K	837K	870K	902K	935K	968K
Total Long-Term Assets	977K	1.05M	2.01M	1.79M	1.92M	11.21M	11.07M	10.93M	10.78M	788K	821K	854K	887K	920K	952K	985K	1.02M
Total Assets	6.73M	6.72M	7.43M	10.71M	10.86M	11.96M	12.21M	12.28M	12.53M	3.24M	2.01M	2.58M	2.72M	3.15M	2.43M	2.54M	3.16M
Account Payables	1.19M	744K	1.7M	n/a	n/a	1.41M	1.17M	506K	1.26M	841K	612K	509K	919K	771K	723K	1.1M	986K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	499K	685K	n/a	n/a	n/a	n/a	n/a	70K	272K	293K	283K
Short-Term Debt	n/a	n/a	n/a	211K	231K	3.67M	1.53M	22.94M	20.04M	7.65M	7.3M	6.97M	6.66M	7.14M	5.6M	3.56M	2.02M
Other Current Liabilities	1.16M	1.62M	11.82M	12.42M	13.83M	829K	506K	1.06M	1.22M	1.59M	899K	1.61M	2.52M	1.06M	275K	606K	923K
Total Current Liabilities	2.35M	2.37M	13.51M	12.63M	14.06M	5.91M	3.2M	24.5M	22.52M	10.08M	8.81M	9.09M	10.1M	8.97M	6.6M	5.27M	3.93M
Long-Term Debt	227K	268K	312K	362K	413K	693K	693K	10.07M	10.01M	10.48M	8.35M	6.76M	4.21M	6.06M	5.81M	5.56M	5.33M
Other Long-Term Liabilities	2.59M	3.58M	7.44M	14.11M	693K	n/a	35.96M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.82M	3.85M	7.75M	14.47M	1.11M	693K	36.65M	10.07M	10.01M	10.48M	8.35M	6.76M	4.21M	6.06M	5.81M	5.56M	5.33M
Total Liabilities	5.17M	6.22M	21.26M	27.1M	15.16M	6.61M	39.85M	34.57M	32.54M	20.56M	17.16M	15.84M	14.31M	15.03M	12.4M	10.84M	9.26M
Total Debt	227K	268K	312K	573K	644K	4.37M	2.22M	33.01M	30.05M	18.12M	15.65M	13.72M	10.87M	13.2M	11.41M	9.12M	7.35M
Common Stock	1K	1K	1K	1K	1K	n/a	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K
Retained Earnings	-49.13M	-44.32M	-21.77M	-23.18M	-5.43M	-131.01M	-127.56M	-122.16M	-119.49M	-116.21M	-113.51M	-111.07M	-108.45M	-105.75M	-103.59M	-101.64M	-99.16M
Comprehensive Income	n/a	n/a	n/a	n/a	-10.86M	n/a	-21.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	1.7M	641K	-13.83M	-16.39M	-4.31M	5.47M	-27.54M	-22.18M	-19.89M	-17.21M	-15.1M	-13.22M	-11.55M	-11.83M	-9.94M	-8.25M	-6.06M
Total Investments	n/a	n/a	n/a	n/a	n/a	10.6M	10.43M	10.25M	10.08M	50K	50K	50K	n/a	n/a	n/a	n/a	n/a